Get the Stockscreener App
0.4175
8.66%
-0.0396
Molecular Templates Inc stock is traded at $0.4175, with a volume of 90,046.
It is down -8.66% in the last 24 hours and down -71.41% over the past month.
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.
See More
Previous Close:
$0.4571
Open:
$0.45
24h Volume:
90,046
Relative Volume:
0.02
Market Cap:
$2.73M
Revenue:
$52.63M
Net Income/Loss:
$-8.12M
P/E Ratio:
-0.0335
EPS:
-12.45
Net Cash Flow:
$-42.02M
1W Performance:
-7.26%
1M Performance:
-71.41%
6M Performance:
-75.00%
1Y Performance:
-91.67%
1-Day Range:
$0.4101
$0.4501
1-Week Range:
$0.4101
$0.4726
52-Week Range:
$0.295
$6.25
Molecular Templates Inc Stock (MTEM) Company Profile
Name
Molecular Templates Inc
Sector
Industry
Phone
512 896 1555
Address
9301 AMBERGLEN BLVD, AUSTIN, TX
Molecular Templates Inc Stock (MTEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-21 | Initiated | BofA Securities | Buy |
| Feb-01-21 | Initiated | UBS | Neutral |
| Sep-08-20 | Initiated | Jefferies | Buy |
| Mar-25-20 | Initiated | Stifel | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Apr-29-19 | Initiated | UBS | Buy |
| Dec-11-18 | Initiated | Oppenheimer | Outperform |
| Oct-08-18 | Initiated | Laidlaw | Buy |
View All
Molecular Templates Inc Stock (MTEM) Latest News
Clairity Appoints Jeffrey R. Luber CEO as Firm Prepares for Global Expansion - cnhinews.com
Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace
Stock Market Movers Today • Top Gainers & Losers - Benzinga
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.47% - MSN
In-vitro Transcription Templates Market to Witness Robust Growth at 19.53% CAGR by 2031 - WhaTech
Bitdeer Technologies Holding Co (NASDAQ: BTDR) Is The Number One Stock Currently Moving. - Stocks Register
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.37% - MSN
Why Spirit Airlines Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket - Benzinga
Global Leukemia Therapeutics Market Overview And Statistics For 2024-2033 - EIN News
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.37% - MSN
Wall Street-Heavily Traded - WDRB
Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Biotech Alert: Searches spiking for these stocks today - TipRanks
why Molecular Templates Inc [MTEM] is a Good Choice for Investors After New Price Target of $18.00 - The DBT News
Closing Bell Recap: Molecular Templates Inc (MTEM) Ends at 0.39, Reflecting a -73.48 Downturn - The Dwinnex
United States shares higher at close of trade; Dow Jones Industrial Average up 0.47% - Investing.com India
MTEM stock touches 52-week low at $0.31 amid market challenges By Investing.com - Investing.com South Africa
MTEM stock touches 52-week low at $0.31 amid market challenges - Investing.com India
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.47% - Investing.com
Dow Surges Over 200 Points; Longboard Pharmaceuticals Shares Jump - Benzinga
A closer look at MTEM’s price-to-free cash flow ratio - US Post News
Molecular Templates Inc (MTEM) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Crude Oil Down Over 2%; Verb Technology Shares Spike Higher - Benzinga
Nasdaq Surges 1%; Boeing Reports 10% Workforce Reduction - Benzinga
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarket - Benzinga
Stocks to Watch: Boeing, Vera Bradley, Molecular Templates - Morningstar
Molecular Templates dips after board approves liquidation plan - XM
Molecular Templates Approves Liquidation, Wind Up of Company - MarketWatch
Molecular Templates : Reorganization Form 8 K - Marketscreener.com
Stocks to Watch : Boeing, Vera Bradley, Molecular Templates - Marketscreener.com
NIKE, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - Simply Wall St
There's No Escaping Molecular Templates, Inc.'s (NASDAQ:MTEM) Muted Revenues Despite A 30% Share Price Rise - Simply Wall St
MTEM Stock Earnings: Molecular Templates Beats EPS, Misses Revenue for Q4 2023 - MSN
Molecular Templates rises on workforce reduction plan - XM
Building better solar cells: assembly of 2D molecular structures with triptycene scaffold - EurekAlert
Molecular Templates holds annual stockholder meeting - Investing.com
Molecular Templates holds annual stockholder meeting By Investing.com - Investing.com UK
Commonwealth Equity Services LLC Has $979,000 Stock Position in TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World
TransMedics Stock: Take Profits While The Valuation Is Sky High (NASDAQ:TMDX) - Seeking Alpha
Traws Pharma Announces Stock Split, Share Adjustments, and Growth Strategy - TipRanks
Traws Pharma, Inc. Announces Special Shareholders Meeting Results - GlobeNewswire
Transmedics Group Inc (TMDX) deserves deeper analysis - US Post News
Tactile Medical's Shares Rise After PDAC Approval for Nimbl - Zacks Investment Research
An analyst sees good growth prospects for Transmedics Group Inc (TMDX) - SETE News
Tactile Medical's new Nimbl system approved for Medicare billing - Investing.com
TransMedics Group, Inc. (NASDAQ:TMDX) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Global Market for In-vitro Transcription Templates to Grow at 19.53% CAGR As Revealed In New Report - WhaTech
Molecular Templates Inc Stock (MTEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):